複数抗血栓薬投与患者における出血性合併症に及ぼす総抗血栓作用の影響

Ichikawa Shinya; Tsukahara Kengo; Kikuchi Shinnosuke; Minamimoto Yugo; Kimura Yuichiro; Okada Kozo; Matsuzawa Yasushi; Konishi Masaaki; Maejima Nobuhiko; Iwahashi Noriaki; Hibi Kiyoshi; Kosuge Masami; Ebina Toshiaki; Tamura Kouichi; Kimura Kazuo

文献

J-GLOBAL ID：201902211386116541 整理番号：19A1475314

複数抗血栓薬投与患者における出血性合併症に及ぼす総抗血栓作用の影響

Impact of Total Antithrombotic Effect on Bleeding Complications in Patients Receiving Multiple Antithrombotic Agents

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1475314&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者 (15件)： , , , , , , , , , , , , , ,
資料名：
巻： 83 号： 6 ページ： 1309-1316(J-STAGE) 発行年： 2019年
JST資料番号： F0908A ISSN： 1346-9843 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：日本 (JPN) 言語：英語 (EN)

背景:複数抗血栓薬の総抗血栓作用を評価した報告はほとんどない...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1475314&from=J-GLOBAL&jstjournalNo=F0908A") }}

著者キーワード (5件)： , , , ,

循環系疾患の薬物療法 , 血液・体液作用薬の臨床への応用

引用文献 (30件)：

1. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: A joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014; 35: 3155-3179.
2. Paikin JS, Wright DS, Crowther MA, Mehta SR, Eikelboom JW. Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. Circulation 2010; 121: 2067-2070.
3. Dewilde WJM, Oirbans T, Verheugt FWA, Kelder JC, De Smet BJGL, Herrman JP, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 2013; 381: 1107-1115.
4. Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 2016; 375: 2423-2434.
5. Hosokawa K, Ohnishi T, Kondo T, Fukasawa M, Koide T, Maruyama I, et al. A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. J Thromb Haemost 2011; 9: 2029-2037.

, , , , ,

前のページに戻る